A comparative description of inotropic agents in vitro.
D000818:Animals; D002110:Caffeine / Q000494:pharmacology*; D002118:Calcium / Q000494:pharmacology*; D002415:Cats; D002478:Cells, Cultured; D003042:Cocaine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005934:Glucagon / Q000494:pharmacology*; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006325:Heart Atria / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology*; D066298:In Vitro Techniques; D008345:Manganese / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects*; D009638:Norepinephrine / Q000494:pharmacology*; D010042:Ouabain / Q000494:pharmacology*; D010210:Papillary Muscles / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology; D011817:Rabbits; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000494:pharmacology*; D013696:Temperature; D013806:Theophylline / Q000494:pharmacology*; D013997:Time Factors
D012701:Serotonin; D002110:Caffeine; D008345:Manganese; D010042:Ouabain; D006632:Histamine; D012110:Reserpine; D005934:Glucagon; D011433:Propranolol; D013806:Theophylline; D003042:Cocaine; D002118:Calcium; D009638:Norepinephrine